论文部分内容阅读
支气管哮喘是一种慢性气道炎症，为探讨其防治问题，我们于1995年10月～1996年1月应用上海天平药厂新近研制的吸入型SCG粉雾剂，每一胶囊含SCG20mg。观察哮喘患儿治疗前后的临床症状、PEFR以及血中NO，sIL－2R含量变化，以评价SCG粉雾剂在儿童哮喘防治中的疗效及实用价值。对象
Bronchial asthma is a chronic airway inflammation, in order to explore the prevention and treatment of the problem, we in October 1995 to January 1996 Shanghai Tianping Pharmaceuticals recently developed inhalation SCG powder aerosol, each capsule containing SCG20mg. To observe the changes of clinical symptoms, PEFR and NO, sIL-2R levels in children with asthma before and after treatment to evaluate the efficacy and practical value of SCG powder aerosol in children with asthma. Object